Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1425-1439

  Wang, Jianwei ^a   Niu, Wen ^a   Nikiforov, Yuri ^a   Naito, Shinji ^a   Chernausek, Steven ^a   Witte, David ^a   LeRoith, Derek ^b   Strauch, Arthur ^c   Fagin, James A ^a,d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Alpha actin; Hyperplasia; IGF binding proteins; Small intestine bladder

Indexed keywords

ALPHA ACTIN; COMPLEMENTARY DNA; DNA; GROWTH FACTOR; MESSENGER RNA; RECOMBINANT SOMATOMEDIN C;

ANIMAL TISSUE; AORTA; ARTICLE; BLADDER; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; INTESTINE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOOTH MUSCLE FIBER; STOMACH; TRANSGENE; TRANSGENIC MOUSE; UTERUS;

EID: 0030830141     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119663     Document Type: Article

References (56)

1. Clemmons, D.R., and J.J. Van Wyk. 1985. Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J. Clin. Invest. 75:1914-1918.
2. Clemmons, D.R. 1985. Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C. Endocrinology. 117:77-83.
3. Khorsandi, M.J., J.A. Fagin, D. Giannella-Neto, J.S. Forrester, and B. Cercek. 1992. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J. Clin. Invest. 90: 1926-1931.
4. Cercek, B., M.C. Fishbein, J.S. Forrester, R.H. Helfant, and J.A. Fagin. 1990. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ. Res. 66:1755-1760.
5. Hayry, P., M. Myllarniemi, E. Aavik, S. Alatalo, P. Aho, S. Yilmaz, A. Raisanen-Sokolowski, G. Cozzone, B.A. Jameson, and R. Baserga. 1995. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:1336-1344.
6. Murphy, L.J. 1991. Estrogen induction of insulin-like growth factors and myc proto-oncogene expression in the uterus. J. Steroid Biochem. Mol. Biol. 40: 223-230.
7. Ghahary, A., S. Chakrabarti, and L.J. Murphy. 1990. Localization of the sites of synthesis and action of insulin-like growth factor-I in the rat uterus. Mol. Endocrinol. 4:191-195.
8. Tang, X.M., M.J. Rossi, B.J. Masterson, and N. Chegini. 1994. Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol. Reprod. 50:1113-1125.
9. Chen, Y., K.E. Bornfeldt, A. Arner, E. Jennische, U. Malmqvist, B. Uvelius, and H.J. Arnqvist. 1994. Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am. J. Physiol. 266:E224-229.
10. Woodcock-Mitchell, J., J.J. Mitchell, R.B. Low, M. Kieny, P. Sengel, L. Rubbia, O. Skalli, B. Jackson, and G. Gabbiani. 1988. Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. Differentiation. 39:161-166.
11. Skalli, O., J. Vandekerckhove, and G. Gabbiani. 1987. Actin-isoform pattern as a marker of normal or pathological smooth-muscle and fibroblastic tissues. Differentiation. 33:232-238.
12. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
13. McHugh, K.M., K. Crawford, and J.L. Lessard. 1991. A comprehensive analysis of the developmental and tissue-specific expression of the isoactin multigene family in the rat. Dev. Biol. 148:442-458.
14. Sawtell, N.M., and J.L. Lessard. 1989. Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma-enteric isoform in differentiating striated myocytes. J. Cell Biol. 109:2929-2937.
15. Miano, J.M., P. Cserjesi, K.L. Ligon, M. Periasamy, and E.N. Olson. 1994. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 75:803-812.
16. Franz, W.M., O.J. Mueller, M. Fleischmann, G. Brem, P. Babij, and H.A. Katus. 1996. The 2.3 kb smooth muscle myosin-heavy-chain promoter directs gene expression to the vascular system of transgenic mice. American Heart Association 69th Scient. Sess. 964 (Abstr.)
17. Li, L., J.M. Miano, B. Mercer, and E.N. Olson. 1996. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:849-859.
18. Li, L., J.M. Miano, P. Cserjesi, and E.N. Olson. 1996. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195.
19. Cogan, J.G., S. Sun, E.S. Stoflet, L.J. Schmidt, M.J. Getz, and A.R. Strauch. 1995. Plasticity of vascular smooth muscle alpha-actin gene transcription. Characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblasts and fibroblasts. J. Biol. Chem. 270:11310-11321.
20. Foster, D.N., B. Min, L.K. Foster, E.S. Stoflet, S. Sun, M.J. Getz, and A.R. Strauch. 1992. Positive and negative cis-acting regulatory elements mediate expression of the mouse vascular smooth muscle alpha-actin gene. J. Biol. Chem. 267:11995-12003.
21. Min, B.H., D.N. Foster, and A.R. Strauch. 1990. The 5′-flanking region of the mouse vascular smooth muscle alpha-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J. Biol. Chem. 265: 16667-16675.
22. Yang, H., M.L. Adamo, A.P. Koval, M.C. McGuinness, H. Ben-Hur, Y. Yang, D. LeRoith, and C.T. Roberts. 1995, Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. Mol. Endocrinol. 9:1380-1395.
23. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
24. Southern, E. 1979. Gel electrophoresis of restriction fragments. Methods Enzymol. 68:152-176.
25. Shackleford, G.M., and H.E. Varmus. 1987. Expression of the protooncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. Cell. 50:89-95.
26. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
27. Hill, D.J., C. Camacho-Hubner, P. Rashid, A.J. Strain, and D.R. Clemmons. 1989. Insulin-like growth factor (IGF)-binding protein release by human fetal fibroblasts: dependency on cell density and IGF peptides. J. Endocrinol. 122:87-98.
28. Furlanetto, R.W., L.E. Underwood, J.J. Van Wyk, and A.J. D'Ercole. 1977. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J. Clin. Invest. 60:648-657.
29. Witte, D.P., B.J. Aronow, J.K. Dry, and J.A. Harmony. 1994. Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis. Dev. Dyn. 201:290-296.
30. Gorman, C.M., L.F. Moffat, and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
31. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.L. Smith, and K. Struhl. 1995. Current Protocols in Molecular Biology. In Anonymous John Wiley and Sons. 60-72.
32. Shibko, S., P. Koivistoinen, C.A. Tratnyek, A.R. Newhall, and L. Friedman. 1967. A method for sequential quantitative separation and determination of protein, RNA, DNA, lipid, and glycogen from a single rat liver homogenate or from a subcellular fraction. Anal. Biochem. 19:514-528.
33. Duan, C., S.B. Hawes, T. Prevette, and D.R. Clemmons. 1996. Insulin-like growth factor-I (IGF-I) regulates IGF-hinding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J. Biol. Chem. 271:4280-4288.
34. Rotwein, P., P.L. James, and K. Kou. 1995. Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol. Endocrinol. 9:913-923.
35. Donath, M.Y., J. Zapf, M. Eppenberger-Eberhardt, E.R. Froesch, and H.M. Eppenberger. 1994. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc. Natl. Acad. Sci. USA. 91:1686-1690.
36. Katoh, Y., E. Loukianov, E. Kopras, A. Zilberman, and M. Periasamy. 1994. Identification of functional promoter elements in the rabbit smooth muscle myosin heavy chain gene. J. Biol. Chem. 269:30538-30545.
37. Babai, F., J. Musevi-Aghdam, W. Schurch, A. Royal, and G. Gabbiani. 1990. Coexpression of alpha-sarcomeric actin, alpha-smooth muscle actin and desmin during myogenesis in rat and mouse embryos I. Skeletal muscle. Differentiation. 44:132-142.
38. Bondy, C.A., H. Werner, C.T. Roberts, and D. LeRoith. 1990. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol. Endocrinol. 4:1386-1398.
39. Liu, J.P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
40. Baker, J., J.P. Liu, E.J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:73-82.
41. Wood, T.L. 1995. Gene-targeting and transgenic approaches to IGF and IGF binding protein function. Am. J. Physiol. 269:E613-622.
42. Quaife, C.J., L.S. Mathews, C.A. Pinkert, R.E. Hammer, R.L. Brinster, and R.D. Palmiter. 1989. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology. 124:40-48.
43. Mathews, L.S., R.E. Hammer, R.L. Brinster, and R.D. Palmiter. 1988. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology. 123:433-437.
44. Mathews, L.S., R.E. Hammer, R.R. Behringer, A.J. D'Ercole, G.I. Bell, R.L. Brinster, and R.D. Palmiter. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology. 123:2827-2833.
45. Palmiter, R.D., G. Norstedt, R.E. Gelinas, R.E. Hammer, and R.L. Brinster. 1983. Metallothionein-human GH fusion genes stimulate growth of mice. Science (Wash. DC). 222:809-814.
46. Palmiter, R.D., R.L. Brinster, R.E. Hammer, M.E. Trumhauer, M.G. Rosenfeld, N.C. Birnberg, and R.M. Evans. 1982. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature (Loud.). 300:611-615.
47. D'Ercole, A.J. 1993. Expression of insulin-like growth factor-I in transgenic mice. Ann. NY Acad. Sci. 692:149-160.
48. Reiss, K., W. Cheng, A. Ferber, J. Kajstura, P. Li, B. Li, G. Olivetti, C.J. Homcy, R. Baserga, and P. Anversa. 1996. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc. Natl. Acad. Sci. USA. 93:8630-8635.
49. Coleman, M.E., F. DeMayo, K.C. Yin, H.M. Lee, R. Geske, C. Montgomery, and R.J. Schwartz. 1995. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270:12109-12116.
50. Brody, J.R., and G.R. Cunha. 1989. Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice. I. Normal development. Am. J. Anat. 186:1-20.
51. Termanini, B., R.V. Nardi, T.M. Finan, I. Parikh, and L.Y. Korman. 1990. Insulin-like growth factor I receptors in rabbit gastrointestinal tract. Characterization and autoradiographic localization. Gastroenterology. 99:51-60.
52. Stevenson, K.R., R.S. Gilmour, and D.C. Wathes. 1994. Localization of insulin-like growth factor-I (IGF-I) and -II messenger ribonucleic acid and type 1 IGF receptors in the ovine uterus during the estrous cycle and early pregnancy. Endocrinology. 134:1655-1664.
53. Ulshen, M.H., R.H. Dowling, C.R. Fuller, E.M. Zimmermann, and P.K. Lund. 1993. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology. 104:973-980.
54. Ohneda, K., M.H. Ulshen, C.R. Fuller, A.J. D'Ercole, and P.K. Lund. 1997. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology. 112:444-454.
55. Lemmey, A.B., F.J. Ballard, A.A. Martin, F.M. Tomas, G.S. Howarth, and L.C. Read. 1994. Treatment with IGF-I peptides improves function of the remnant gut following small bowel resection in rats. Growth Factors. 10:243-252.
56. Kelley, K.M., Y. Oh, S.E. Gargosky, Z. Gucev, T. Matsumoto, V. Hwa, L. Ng, D.M. Simpson, and R.G. Rosenfeld. 1996. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28:619-637.